4//SEC Filing
Cadavid Diego 4
Accession 0001628280-22-004495
CIK 0001501697other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:08 PM ET
Size
5.4 KB
Accession
0001628280-22-004495
Insider Transaction Report
Form 4
Cadavid Diego
Chief Medical Officer
Transactions
- Award
Common Stock
2022-03-01+97,000→ 104,107 total
Footnotes (2)
- [F1]Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in two equal annual installments on March 1, 2023 and March 1, 2024, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
- [F2]Of the shares of common stock reported, 102,357 shares represent unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001778713
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:08 PM ET
- Size
- 5.4 KB